Navigation Links
Metabolix Announces Second Quarter 2013 Financial Results
Date:7/31/2013

tions for manufacturing at that site. In addition, we are conducting due diligence on two potential U.S. manufacturing sites."

"In our biobased chemicals and crop platforms, we continue to achieve our internal technical milestones," said Mr. Eno. "We had three new patents issued and three allowed during the quarter, spanning each of our three businesses. This intellectual property is an important asset for Metabolix, as it creates potential commercial opportunities for us while strengthening our competitive position. As we move into the second half of 2013, we look forward to executing on our business plan and expanding our presence to meet the growing demand in our high-value markets."

SECOND QUARTER AND SIX MONTHS 2013 FINANCIAL OVERVIEWMetabolix manages its finances with an emphasis on cash flow. The Company has maintained this focus and ended the second quarter with $31.7 million in unrestricted cash and investments. The Company's net cash used for operating activities during the second quarter of 2013 was $5.8 million, which remains consistent with net cash used of $5.9 million for the comparable quarter in 2012.  Metabolix continues to have no debt.

Total revenue in the second quarter of 2013 was $1.7 million, compared to $0.9 million for the comparable quarter in 2012. The second quarter revenue consisted primarily of revenue from product sales and work performed on government research grants.  Grant revenue of $0.6 million increased by $0.1 million over the same quarter of 2012, primarily as a result of work performed on the Renewable Enhanced Feedstocks for Advanced Biofuels and Bioproducts ("REFABB") grant awarded by the U.S. Department of Energy. Biopolymer product orders of $0.4 million were shipped and billed during the Company's second quarter of 2013. Revenue recognition was deferred for the majority of these shipments in accordance with the Company's policy to defer product revenue for the greater of 60 days or until
'/>"/>

SOURCE Metabolix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Metabolix Announces Promotion of Johan van Walsem to Chief Operating Officer
2. Metabolix Executives to Present at Leading Industry Conferences
3. Life Technologies Announces Second Quarter 2013 Results
4. BioAstrum Announces New Transfection Tools Market Report
5. MiMedx Announces Record Second Quarter Results
6. SoundConnect Announces Expansion into New York City and Washington D.C.
7. DryLet Technologies Announces the Rebranding and Launch of Patented ManureMagic™
8. Pittcon 2014 Announces Call for Topics for Conferee Networking Sessions
9. Celladon Corporation Announces Pre-clinical Study Demonstrating Inhalable MYDICAR Reverses Pulmonary Arterial Hypertension (PAH)
10. Amgen Announces 2013 Third Quarter Dividend
11. Hie Electronics Announces the Launch of Its TeraNimbus Cloud Archive and Backup and TeraNimbus Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Burkina Faso (PRWEB) July 10, 2014 ... Faso, today have access to an additional family ... increase access to contraception at all levels of ... a lower-dose formulation of a widely used contraceptive—Pfizer’s ... system. , Burkina Faso is the first of ...
(Date:7/10/2014)... Terascala, the industry leader in HPC ... former vice president of product management for Flexera Software, ... marketing. Terascala’s software when combined with leading compute and ... performance and most reliable solutions for processing big data. ... expansion and broaden its product portfolio. His leadership in ...
(Date:7/10/2014)... QC (PRWEB) July 10, 2014 EvoDerma ... and convenience. This rejuvenating device now comes with a second ... develops over time. , The new cup is thinner on ... design works to target rough, thin and uneven surfaces on ... firm cup for a stimulating treatment on areas such as ...
(Date:7/10/2014)...  Kainos Capital, a firm specializing in acquiring and ... has acquired the Slim-Fast brand from Unilever. Unilever will ... the transaction were not disclosed. Slim-Fast is ... markets ready-to-drink shakes, powders, bars and snacks to retail ... in the United Kingdom and ...
Breaking Biology Technology:Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Terascala Expands Executive Team 2Terascala Expands Executive Team 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Kainos Capital Acquires Slim-Fast From Unilever 2
... Minds, Establishes New Company to Commercialize ... Novel Technology from UC ... investment,firm specializing in early stage university business ventures, has,established RF ... technology invented at UC Davis., The newly formed RF ...
... TAIAN CITY, Shandong, China, June 30 /Xinhua-PRNewswire-FirstCall/ --,China ... or "the,Company"), one of the leading plasma-based pharmaceutical ... announced that the Company,received the approval from the ... new plasma collection station in Pu Bei County, ...
... Cellumen, Inc., the Cellular,Systems Biology Company, announced today ... Center for Toxicology Research (NCTR), a,research center of ... Cellumen will use its proprietary CellCiphr(R) toxicity risk,assessment ... toxicity,compounds including both failed and marketed drugs for ...
Cached Biology Technology:Allied Minds Launches Novel Disinfectant/Disinfestant Technology Start-up With UC Davis 2China Biologic Products Announces Approval for Setting Up a New Plasma Collection Station in Pu Bei County, Guangxi Province 2China Biologic Products Announces Approval for Setting Up a New Plasma Collection Station in Pu Bei County, Guangxi Province 3Cellumen to Collaborate With the NCTR of the FDA to Apply Cellular Systems Biology (CSB(TM)) to Predictive Toxicology 2
(Date:7/10/2014)... -- It is a great honor for Avery Biomedical ... world-renowned Thoracic and Cardiovascular surgeon, Mark E Ginsburg, M.D., ... with over 34 years of experience, is currently practicing ... Regional Medical Center. Dr. Ginsburg has been implanting the ... considered an expert in the implantation of the Avery ...
(Date:7/10/2014)... 2014 According to the new ... And Area), Material (Optical Prism, Pizeoelectric, Capacitive, and Adhesives), ... Banking & Finance), and Geography - Global Trends & ... global Fingerprint Sensors Market is projected to cross $14.35 ... 16.8% from 2014 to 2020. Browse more ...
(Date:7/10/2014)... 7, 2014 Fingerprint Cards, (FPC,s) new ... win (DW). A Chinese Top 5 smartphone OEM has selected ... mass production in October 2014.   FPC is ... smartphone OEM, which has a planned date for the start ... volume for this phone of 3 million units. The Chinese ...
Breaking Biology News(10 mins):Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2Fingerprint Sensors Market worth $14.35 Billion by 2020 2Fingerprint Sensors Market worth $14.35 Billion by 2020 3FPC Wins DW for 1021 Touch Sensor for Flagship Smartphone from Chinese Top 5 Smartphone OEM 2
... Health has named researchers at Baylor College of Medicine ... and only recipients of the inaugural Quantum Grant for ... and blood vessels for the treatment of stroke. , ... Institute of Biomedical Imaging and Bioengineering (NIBIB), part of ...
... two candidate vaccines that may eventually be used together ... are published in the December 15 issue of The ... S. Graham, MD, PhD, and colleagues from the National ... the Fred Hutchinson Cancer Research Center in Seattle, and ...
... heart muscle ?even though it was grown in the ... the goal of creating replacement parts for damaged human ... just a spoonful of loose heart cells. , This ... in growing bioengineered heart muscle, or BEHM, with organized ...
Cached Biology News:First Quantum Grant to fund stem cell repair of damage from stroke 2Progress made in HIV vaccine development 2A new approach to growing heart muscle 2A new approach to growing heart muscle 3A new approach to growing heart muscle 4
Contact us for more information...
... System enables you to insert a transposable ... DNA by in vitro transposition. It uses ... into the DNA target. Target DNA may ... DNA, depending on your interests (6-8). If ...
... APAgene kits are designed to rapidly ... using our patented APA Technology. ... at an extraordinarily competitive price. All ... kit. The Locator Kit can be ...
... c-Jun N-terminal kinase (JNK) is one ... Firefly luciferase has been used as a ... function. Luciferase provides a 1000-fold increase in ... acetyltransferase (CAT) assay. Firefly luciferase catalyzes the ...
Biology Products: